| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0093-0308-01 | 0093-0308 | HUMAN PRESCRIPTION DRUG | Clemastine Fumarate | Clemastine Fumarate | TABLET | ORAL | 19920401 | 20260331 | ANDA | ANDA073283 | Teva Pharmaceuticals USA, Inc. | CLEMASTINE FUMARATE | 2.68 mg/1 | 100 TABLET in 1 BOTTLE (0093-0308-01) |
| 64950-268-03 | 64950-268 | HUMAN PRESCRIPTION DRUG | Clemastine Fumarate | Clemastine Fumarate | TABLET | ORAL | 20241120 | N/A | ANDA | ANDA073283 | Genus Lifesciences | CLEMASTINE FUMARATE | 2.68 mg/1 | 30 TABLET in 1 BOTTLE (64950-268-03) |
| 64950-268-10 | 64950-268 | HUMAN PRESCRIPTION DRUG | Clemastine Fumarate | Clemastine Fumarate | TABLET | ORAL | 20241120 | N/A | ANDA | ANDA073283 | Genus Lifesciences | CLEMASTINE FUMARATE | 2.68 mg/1 | 100 TABLET in 1 BOTTLE (64950-268-10) |